EGFR/HER2 Exon 20 Insertion Mutation Clinical Trials in Philadelphia, Pennsylvania

First-In-Human Study of STX-721/PFL-721 in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring EGFR or HER2 Exon 20 Insertion Mutations